IMMUNIC INC's ticker is IMUX and the CUSIP is 4525EP101. A total of 66 filers reported holding IMMUNIC INC in Q1 2021. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $598 | -41.5% | 407 | 0.0% | 0.00% | – |
Q2 2023 | $1,022 | +2.2% | 407 | 0.0% | 0.00% | – |
Q1 2023 | $1,000 | +2757.1% | 407 | -98.4% | 0.00% | – |
Q4 2022 | $35 | -99.4% | 24,903 | +1143.9% | 0.00% | – |
Q3 2022 | $6,000 | -33.3% | 2,002 | -28.2% | 0.00% | – |
Q2 2022 | $9,000 | -94.2% | 2,790 | -79.6% | 0.00% | – |
Q1 2022 | $154,000 | +42.6% | 13,649 | +21.2% | 0.00% | – |
Q4 2021 | $108,000 | +20.0% | 11,262 | +9.4% | 0.00% | – |
Q3 2021 | $90,000 | -13.5% | 10,297 | +21.0% | 0.00% | – |
Q2 2021 | $104,000 | +215.2% | 8,509 | +305.2% | 0.00% | – |
Q1 2021 | $33,000 | -13.2% | 2,100 | -15.2% | 0.00% | – |
Q4 2020 | $38,000 | -2.6% | 2,477 | +19.3% | 0.00% | – |
Q3 2020 | $39,000 | +8.3% | 2,076 | -29.3% | 0.00% | – |
Q2 2020 | $36,000 | – | 2,935 | +48816.7% | 0.00% | – |
Q4 2019 | $0 | -100.0% | 6 | -99.5% | 0.00% | – |
Q3 2019 | $13,000 | – | 1,275 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
AWH Capital, L.P. | 1,000,000 | $1,400,000 | 0.88% |
Omega Fund Management, LLC | 1,788,160 | $2,503,424 | 0.84% |
COMMODORE CAPITAL LP | 1,800,000 | $2,520 | 0.38% |
Ikarian Capital, LLC | 650,000 | $910,000 | 0.22% |
Gratus Capital, LLC | 1,668,294 | $2,335,612 | 0.19% |
GREAT POINT PARTNERS LLC | 632,184 | $885,058 | 0.17% |
Parkman Healthcare Partners LLC | 459,770 | $643,678 | 0.17% |
Anson Funds Management LP | 664,935 | $930,909 | 0.15% |
SILVERARC CAPITAL MANAGEMENT, LLC | 350,656 | $490,918 | 0.14% |
COWEN AND COMPANY, LLC | 791,024 | $1,107,433 | 0.12% |